Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Identifier
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers. 12. 4. 2020. -. -. Art. 793
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wer)
-
Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
- (wann)
-
2020
- Urheber
-
Beck, Olaf
Paret, Claudia
Russo, Alexandra
Burhenne, Jürgen
Fresnais, Margaux
Steimel, Kevin
Seidmann, Larissa
Wagner, Daniel-Christoph
Vewinger, Nadine
Lehmann, Nadine
Sprang, Maximilian
Backes, Nora
Roth, Lea
Neu, Marie Astrid
Wingerter, Arthur
Henninger, Nicole
EL Malki, Khalifa
Otto, Henrike
Alt, Francesca
Desuki, Alexander
Kindler, Thomas
Faber, Jörg
- DOI
-
10.25358/openscience-5222
- Handle
- URN
-
urn:nbn:de:101:1-2020121413570427814340
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Beck, Olaf
- Paret, Claudia
- Russo, Alexandra
- Burhenne, Jürgen
- Fresnais, Margaux
- Steimel, Kevin
- Seidmann, Larissa
- Wagner, Daniel-Christoph
- Vewinger, Nadine
- Lehmann, Nadine
- Sprang, Maximilian
- Backes, Nora
- Roth, Lea
- Neu, Marie Astrid
- Wingerter, Arthur
- Henninger, Nicole
- EL Malki, Khalifa
- Otto, Henrike
- Alt, Francesca
- Desuki, Alexander
- Kindler, Thomas
- Faber, Jörg
- Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
Entstanden
- 2020
Ähnliche Objekte (12)
Dasatinib—A Generation Ahead
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways
Fluoride levels and osteosarcoma
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma
New dosing schedules of dasatinib for CML and adverse event management
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Massage manipulation and progression of osteosarcoma, does it really correlate: a combination of prospective and retrospective cohort study
Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
Dasatinib—A Generation Ahead
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways
Fluoride levels and osteosarcoma
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma
New dosing schedules of dasatinib for CML and adverse event management
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Massage manipulation and progression of osteosarcoma, does it really correlate: a combination of prospective and retrospective cohort study
Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
Dasatinib—A Generation Ahead
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways
Fluoride levels and osteosarcoma
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma
New dosing schedules of dasatinib for CML and adverse event management
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Massage manipulation and progression of osteosarcoma, does it really correlate: a combination of prospective and retrospective cohort study